Dermapharm Holding SE (STU:DMP) Forward Dividend Yield % : 2.44% (As of Jun. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Forward Dividend Yield %?

As of today (2024-06-22), the Forward Annual Dividend Yield of Dermapharm Holding SE is 2.44%.

As of today (2024-06-22), the Trailing Annual Dividend Yield of Dermapharm Holding SE is 2.92%.

STU:DMP's Forward Dividend Yield % is ranked better than
61.07% of 488 companies
in the Drug Manufacturers industry
Industry Median: 1.905 vs STU:DMP: 2.44

Dermapharm Holding SE's Dividends per Share for the three months ended in Mar. 2024 was €0.00.

During the past 12 months, Dermapharm Holding SE's average Dividends Per Share Growth Rate was -51.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 9.50% per year.

During the past 11 years, the highest 3-Year average Dividends Per Share Growth Rate of Dermapharm Holding SE was 41.30% per year. The lowest was 9.50% per year. And the median was 25.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Dermapharm Holding SE's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dermapharm Holding SE's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Forward Dividend Yield % falls into.

Dermapharm Holding SE Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Dermapharm Holding SE (STU:DMP) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Dermapharm Holding SE Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE (STU:DMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (STU:DMP) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

0A5J:UK DMP:Germany

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.de

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals and cosmetics products. Parallel import brands business operates under the AxiCorp brand.

Dermapharm Holding SE (STU:DMP) Headlines

No Headlines